Company / Working Capital per Share
Edwards Lifesciences Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$8.48
FY2025
5-year range
$3.41 / $8.48
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
#48 of 158
Health Care
What the data says
At $8.48, Edwards Lifesciences's working capital per share ranks #48 of 158 in the Health Care sector. Working Capital per Share has increased for 3 consecutive years, from $3.41 in FY2022 to $8.48 in FY2025.
Based on SEC 10-K filings.
8.48 in FY2025 with a 5-year CAGR of +19.2%.
Improved from $4.67 to $8.48 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +35.5%
- 5-Year CAGR
- +19.2%
- 10-Year CAGR
- -
Sector benchmark
#48 of 158 in Health CareTop 30% of 158This company $8.48 Sector average $24.43
▼
-65.3% below sector average
Key checks
Key Insights
- Edwards Lifesciences's working capital per share has grown for 3 consecutive years.
- In FY2025, working capital per share increased 6.7% year-over-year.
- Ranks #48 out of 158 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.48 | +6.7% |
| FY2024 | $7.95 | +70.3% |
| FY2023 | $4.67 | +37.0% |
| FY2022 | $3.41 | -1.0% |
| FY2021 | $3.44 | -2.2% |
| FY2020 | $3.52 | -64.6% |
| FY2019 | $9.96 | +46.6% |
| FY2018 | $6.79 | +27.2% |
| FY2017 | $5.34 | -33.9% |
| FY2016 | $8.07 | -44.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026